Skip to main content
. Author manuscript; available in PMC: 2018 Jul 10.
Published in final edited form as: Life Sci. 2015 Jan 24;124:81–90. doi: 10.1016/j.lfs.2015.01.005

Fig. 8.

Fig. 8

Tubulointerstitial infiltration of macrophages (CD68+ cells) A). After two weeks of NO inhibition, the L-NAME treated rat (solid bar) had a significant increment of CD68+ cells when compared to Controls. Losartan treatment (L-NAME + Los) did not have any effect on tubulointerstitial infiltration of CD68+ cells. Each bar shows means ± SD (n = 6). **p < 0.01 versus Control. Tubulointerstitial infiltration of lymphocytes (CD5+ cells). B) L-NAME treated rats (solid bar) had a significant increment of CD5+ cells (**p < 0.05 versus Control). Values are mean ± SD; n = 6. C) Representative photomicrographs of CD5 staining from renal cross-sections of the kidney show CD5 positive cells (arrows) in tubulointerstitial areas of Control, L-NAME and L-NAME + Los rats. Magnification 400×.